img

Global Respiratory Infectious Disease Diagnostics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Respiratory Infectious Disease Diagnostics Market Research Report 2024

Respiratory Infectious Disease Diagnostics mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.
According to MRAResearch’s new survey, global Respiratory Infectious Disease Diagnostics market is projected to reach US$ 75130 million in 2033, increasing from US$ 64120 million in 2022, with the CAGR of 2.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Respiratory Infectious Disease Diagnostics market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Respiratory Infectious Disease Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Thermo Fisher Scientific.
Koninklijke Philips
Cardinal Health
COSMED
Smiths Group
NIHON KOHDEN CORPORATION
Becton
Dickinson
F.Hoffmann
bioMérieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen
GENERAL ELECTRIC COMPANY
Medtronic
Novartis AG
Johnson & Johnson Services Inc
GlaxoSmithKline plc
Drägerwerk AG & Co. KGaA
GC Diagnostics Corporation
Bayer AG
Masimo
Carestream Health
Segment by Type
Mechanical Tests
Imaging Tests
In Vitro Diagnostics (IVD) Tests

Segment by Application


Hospitals
Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Respiratory Infectious Disease Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Mechanical Tests
1.2.3 Imaging Tests
1.2.4 In Vitro Diagnostics (IVD) Tests
1.3 Market by Application
1.3.1 Global Respiratory Infectious Disease Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Infectious Disease Diagnostics Market Perspective (2018-2033)
2.2 Respiratory Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Global Respiratory Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Respiratory Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Respiratory Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Respiratory Infectious Disease Diagnostics Market Dynamics
2.3.1 Respiratory Infectious Disease Diagnostics Industry Trends
2.3.2 Respiratory Infectious Disease Diagnostics Market Drivers
2.3.3 Respiratory Infectious Disease Diagnostics Market Challenges
2.3.4 Respiratory Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Infectious Disease Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Infectious Disease Diagnostics Revenue
3.4 Global Respiratory Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Infectious Disease Diagnostics Revenue in 2022
3.5 Respiratory Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033)
5 Respiratory Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
6.2 North America Respiratory Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
6.4 North America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
7.2 Europe Respiratory Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
7.4 Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
9.2 Latin America Respiratory Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Thermo Fisher Scientific.
11.2.1 Thermo Fisher Scientific. Company Detail
11.2.2 Thermo Fisher Scientific. Business Overview
11.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Introduction
11.2.4 Thermo Fisher Scientific. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific. Recent Development
11.3 Koninklijke Philips
11.3.1 Koninklijke Philips Company Detail
11.3.2 Koninklijke Philips Business Overview
11.3.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Introduction
11.3.4 Koninklijke Philips Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.3.5 Koninklijke Philips Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Detail
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Respiratory Infectious Disease Diagnostics Introduction
11.4.4 Cardinal Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.4.5 Cardinal Health Recent Development
11.5 COSMED
11.5.1 COSMED Company Detail
11.5.2 COSMED Business Overview
11.5.3 COSMED Respiratory Infectious Disease Diagnostics Introduction
11.5.4 COSMED Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.5.5 COSMED Recent Development
11.6 Smiths Group
11.6.1 Smiths Group Company Detail
11.6.2 Smiths Group Business Overview
11.6.3 Smiths Group Respiratory Infectious Disease Diagnostics Introduction
11.6.4 Smiths Group Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.6.5 Smiths Group Recent Development
11.7 NIHON KOHDEN CORPORATION
11.7.1 NIHON KOHDEN CORPORATION Company Detail
11.7.2 NIHON KOHDEN CORPORATION Business Overview
11.7.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Introduction
11.7.4 NIHON KOHDEN CORPORATION Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.7.5 NIHON KOHDEN CORPORATION Recent Development
11.8 Becton
11.8.1 Becton Company Detail
11.8.2 Becton Business Overview
11.8.3 Becton Respiratory Infectious Disease Diagnostics Introduction
11.8.4 Becton Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.8.5 Becton Recent Development
11.9 Dickinson
11.9.1 Dickinson Company Detail
11.9.2 Dickinson Business Overview
11.9.3 Dickinson Respiratory Infectious Disease Diagnostics Introduction
11.9.4 Dickinson Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.9.5 Dickinson Recent Development
11.10 F.Hoffmann
11.10.1 F.Hoffmann Company Detail
11.10.2 F.Hoffmann Business Overview
11.10.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Introduction
11.10.4 F.Hoffmann Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.10.5 F.Hoffmann Recent Development
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Detail
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Respiratory Infectious Disease Diagnostics Introduction
11.11.4 bioMérieux SA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.11.5 bioMérieux SA Recent Development
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Detail
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.12.5 Bio-Rad Laboratories, Inc. Recent Development
11.13 Quidel Corporation
11.13.1 Quidel Corporation Company Detail
11.13.2 Quidel Corporation Business Overview
11.13.3 Quidel Corporation Respiratory Infectious Disease Diagnostics Introduction
11.13.4 Quidel Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.13.5 Quidel Corporation Recent Development
11.14 Siemens Healthcare GmbH
11.14.1 Siemens Healthcare GmbH Company Detail
11.14.2 Siemens Healthcare GmbH Business Overview
11.14.3 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Introduction
11.14.4 Siemens Healthcare GmbH Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.14.5 Siemens Healthcare GmbH Recent Development
11.15 Danaher
11.15.1 Danaher Company Detail
11.15.2 Danaher Business Overview
11.15.3 Danaher Respiratory Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.15.5 Danaher Recent Development
11.16 Qiagen
11.16.1 Qiagen Company Detail
11.16.2 Qiagen Business Overview
11.16.3 Qiagen Respiratory Infectious Disease Diagnostics Introduction
11.16.4 Qiagen Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.16.5 Qiagen Recent Development
11.17 GENERAL ELECTRIC COMPANY
11.17.1 GENERAL ELECTRIC COMPANY Company Detail
11.17.2 GENERAL ELECTRIC COMPANY Business Overview
11.17.3 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Introduction
11.17.4 GENERAL ELECTRIC COMPANY Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.17.5 GENERAL ELECTRIC COMPANY Recent Development
11.18 Medtronic
11.18.1 Medtronic Company Detail
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Respiratory Infectious Disease Diagnostics Introduction
11.18.4 Medtronic Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.18.5 Medtronic Recent Development
11.19 Novartis AG
11.19.1 Novartis AG Company Detail
11.19.2 Novartis AG Business Overview
11.19.3 Novartis AG Respiratory Infectious Disease Diagnostics Introduction
11.19.4 Novartis AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.19.5 Novartis AG Recent Development
11.20 Johnson & Johnson Services Inc
11.20.1 Johnson & Johnson Services Inc Company Detail
11.20.2 Johnson & Johnson Services Inc Business Overview
11.20.3 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Introduction
11.20.4 Johnson & Johnson Services Inc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.20.5 Johnson & Johnson Services Inc Recent Development
11.21 GlaxoSmithKline plc
11.21.1 GlaxoSmithKline plc Company Detail
11.21.2 GlaxoSmithKline plc Business Overview
11.21.3 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Introduction
11.21.4 GlaxoSmithKline plc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.21.5 GlaxoSmithKline plc Recent Development
11.22 Drägerwerk AG & Co. KGaA
11.22.1 Drägerwerk AG & Co. KGaA Company Detail
11.22.2 Drägerwerk AG & Co. KGaA Business Overview
11.22.3 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Introduction
11.22.4 Drägerwerk AG & Co. KGaA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.22.5 Drägerwerk AG & Co. KGaA Recent Development
11.23 GC Diagnostics Corporation
11.23.1 GC Diagnostics Corporation Company Detail
11.23.2 GC Diagnostics Corporation Business Overview
11.23.3 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Introduction
11.23.4 GC Diagnostics Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.23.5 GC Diagnostics Corporation Recent Development
11.24 Bayer AG
11.24.1 Bayer AG Company Detail
11.24.2 Bayer AG Business Overview
11.24.3 Bayer AG Respiratory Infectious Disease Diagnostics Introduction
11.24.4 Bayer AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.24.5 Bayer AG Recent Development
11.25 Masimo
11.25.1 Masimo Company Detail
11.25.2 Masimo Business Overview
11.25.3 Masimo Respiratory Infectious Disease Diagnostics Introduction
11.25.4 Masimo Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.25.5 Masimo Recent Development
11.26 Carestream Health
11.26.1 Carestream Health Company Detail
11.26.2 Carestream Health Business Overview
11.26.3 Carestream Health Respiratory Infectious Disease Diagnostics Introduction
11.26.4 Carestream Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.26.5 Carestream Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Mechanical Tests
Table 3. Key Players of Imaging Tests
Table 4. Key Players of In Vitro Diagnostics (IVD) Tests
Table 5. Global Respiratory Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Respiratory Infectious Disease Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Respiratory Infectious Disease Diagnostics Market Share by Region (2018-2023)
Table 9. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Respiratory Infectious Disease Diagnostics Market Share by Region (2024-2033)
Table 11. Respiratory Infectious Disease Diagnostics Market Trends
Table 12. Respiratory Infectious Disease Diagnostics Market Drivers
Table 13. Respiratory Infectious Disease Diagnostics Market Challenges
Table 14. Respiratory Infectious Disease Diagnostics Market Restraints
Table 15. Global Respiratory Infectious Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Respiratory Infectious Disease Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top Respiratory Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2022)
Table 18. Ranking of Global Top Respiratory Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Respiratory Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Respiratory Infectious Disease Diagnostics Product Solution and Service
Table 22. Date of Enter into Respiratory Infectious Disease Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Application (2024-2033)
Table 32. North America Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Respiratory Infectious Disease Diagnostics Product
Table 50. Abbott Laboratories Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Thermo Fisher Scientific. Company Detail
Table 53. Thermo Fisher Scientific. Business Overview
Table 54. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product
Table 55. Thermo Fisher Scientific. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific. Recent Development
Table 57. Koninklijke Philips Company Detail
Table 58. Koninklijke Philips Business Overview
Table 59. Koninklijke Philips Respiratory Infectious Disease Diagnostics Product
Table 60. Koninklijke Philips Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 61. Koninklijke Philips Recent Development
Table 62. Cardinal Health Company Detail
Table 63. Cardinal Health Business Overview
Table 64. Cardinal Health Respiratory Infectious Disease Diagnostics Product
Table 65. Cardinal Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 66. Cardinal Health Recent Development
Table 67. COSMED Company Detail
Table 68. COSMED Business Overview
Table 69. COSMED Respiratory Infectious Disease Diagnostics Product
Table 70. COSMED Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 71. COSMED Recent Development
Table 72. Smiths Group Company Detail
Table 73. Smiths Group Business Overview
Table 74. Smiths Group Respiratory Infectious Disease Diagnostics Product
Table 75. Smiths Group Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Smiths Group Recent Development
Table 77. NIHON KOHDEN CORPORATION Company Detail
Table 78. NIHON KOHDEN CORPORATION Business Overview
Table 79. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product
Table 80. NIHON KOHDEN CORPORATION Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 81. NIHON KOHDEN CORPORATION Recent Development
Table 82. Becton Company Detail
Table 83. Becton Business Overview
Table 84. Becton Respiratory Infectious Disease Diagnostics Product
Table 85. Becton Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 86. Becton Recent Development
Table 87. Dickinson Company Detail
Table 88. Dickinson Business Overview
Table 89. Dickinson Respiratory Infectious Disease Diagnostics Product
Table 90. Dickinson Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 91. Dickinson Recent Development
Table 92. F.Hoffmann Company Detail
Table 93. F.Hoffmann Business Overview
Table 94. F.Hoffmann Respiratory Infectious Disease Diagnostics Product
Table 95. F.Hoffmann Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 96. F.Hoffmann Recent Development
Table 97. bioMérieux SA Company Detail
Table 98. bioMérieux SA Business Overview
Table 99. bioMérieux SA Respiratory Infectious Disease Diagnostics Product
Table 100. bioMérieux SA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 101. bioMérieux SA Recent Development
Table 102. Bio-Rad Laboratories, Inc. Company Detail
Table 103. Bio-Rad Laboratories, Inc. Business Overview
Table 104. Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Product
Table 105. Bio-Rad Laboratories, Inc. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 106. Bio-Rad Laboratories, Inc. Recent Development
Table 107. Quidel Corporation Company Detail
Table 108. Quidel Corporation Business Overview
Table 109. Quidel Corporation Respiratory Infectious Disease Diagnostics Product
Table 110. Quidel Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 111. Quidel Corporation Recent Development
Table 112. Siemens Healthcare GmbH Company Detail
Table 113. Siemens Healthcare GmbH Business Overview
Table 114. Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Product
Table 115. Siemens Healthcare GmbH Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 116. Siemens Healthcare GmbH Recent Development
Table 117. Danaher Company Detail
Table 118. Danaher Business Overview
Table 119. Danaher Respiratory Infectious Disease Diagnostics Product
Table 120. Danaher Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 121. Danaher Recent Development
Table 122. Qiagen Company Detail
Table 123. Qiagen Business Overview
Table 124. Qiagen Respiratory Infectious Disease Diagnostics Product
Table 125. Qiagen Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 126. Qiagen Recent Development
Table 127. GENERAL ELECTRIC COMPANY Company Detail
Table 128. GENERAL ELECTRIC COMPANY Business Overview
Table 129. GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Product
Table 130. GENERAL ELECTRIC COMPANY Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 131. GENERAL ELECTRIC COMPANY Recent Development
Table 132. Medtronic Company Detail
Table 133. Medtronic Business Overview
Table 134. Medtronic Respiratory Infectious Disease Diagnostics Product
Table 135. Medtronic Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 136. Medtronic Recent Development
Table 137. Novartis AG Company Detail
Table 138. Novartis AG Business Overview
Table 139. Novartis AG Respiratory Infectious Disease Diagnostics Product
Table 140. Novartis AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 141. Novartis AG Recent Development
Table 142. Johnson & Johnson Services Inc Company Detail
Table 143. Johnson & Johnson Services Inc Business Overview
Table 144. Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Product
Table 145. Johnson & Johnson Services Inc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 146. Johnson & Johnson Services Inc Recent Development
Table 147. GlaxoSmithKline plc Company Detail
Table 148. GlaxoSmithKline plc Business Overview
Table 149. GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Product
Table 150. GlaxoSmithKline plc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 151. GlaxoSmithKline plc Recent Development
Table 152. Drägerwerk AG & Co. KGaA Company Detail
Table 153. Drägerwerk AG & Co. KGaA Business Overview
Table 154. Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Product
Table 155. Drägerwerk AG & Co. KGaA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 156. Drägerwerk AG & Co. KGaA Recent Development
Table 157. GC Diagnostics Corporation Company Detail
Table 158. GC Diagnostics Corporation Business Overview
Table 159. GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Product
Table 160. GC Diagnostics Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 161. GC Diagnostics Corporation Recent Development
Table 162. Bayer AG Company Detail
Table 163. Bayer AG Business Overview
Table 164. Bayer AG Respiratory Infectious Disease Diagnostics Product
Table 165. Bayer AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 166. Bayer AG Recent Development
Table 167. Masimo Company Detail
Table 168. Masimo Business Overview
Table 169. Masimo Respiratory Infectious Disease Diagnostics Product
Table 170. Masimo Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 171. Masimo Recent Development
Table 172. Carestream Health Company Detail
Table 173. Carestream Health Business Overview
Table 174. Carestream Health Respiratory Infectious Disease Diagnostics Product
Table 175. Carestream Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 176. Carestream Health Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Infectious Disease Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Respiratory Infectious Disease Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Mechanical Tests Features
Figure 4. Imaging Tests Features
Figure 5. In Vitro Diagnostics (IVD) Tests Features
Figure 6. Global Respiratory Infectious Disease Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Respiratory Infectious Disease Diagnostics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinical Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Respiratory Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Respiratory Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Respiratory Infectious Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Respiratory Infectious Disease Diagnostics Market Share by Region: 2022 VS 2033
Figure 15. Global Respiratory Infectious Disease Diagnostics Market Share by Players in 2022
Figure 16. Global Top Respiratory Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Infectious Disease Diagnostics Revenue in 2022
Figure 18. North America Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 20. United States Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 24. Germany Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Respiratory Infectious Disease Diagnostics Market Share by Region (2018-2033)
Figure 32. China Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 40. Mexico Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 44. Turkey Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 47. Thermo Fisher Scientific. Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 48. Koninklijke Philips Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 49. Cardinal Health Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 50. COSMED Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 51. Smiths Group Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 52. NIHON KOHDEN CORPORATION Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 53. Becton Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 54. Dickinson Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 55. F.Hoffmann Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 56. bioMérieux SA Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 57. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 58. Quidel Corporation Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 59. Siemens Healthcare GmbH Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 60. Danaher Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 61. Qiagen Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 62. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 63. Medtronic Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 64. Novartis AG Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 65. Johnson & Johnson Services Inc Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 66. GlaxoSmithKline plc Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 67. Drägerwerk AG & Co. KGaA Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 68. GC Diagnostics Corporation Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 69. Bayer AG Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 70. Masimo Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 71. Carestream Health Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries